| 000 | 02662 a2200649 4500 | ||
|---|---|---|---|
| 005 | 20250513163713.0 | ||
| 264 | 0 | _c19990413 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aManna, S K | |
| 245 | 0 | 0 |
_aImmunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cFeb 1999 |
||
| 300 |
_a2095-102 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAniline Compounds _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aBiological Transport _xdrug effects |
| 650 | 0 | 4 |
_aCell Nucleus _xdrug effects |
| 650 | 0 | 4 |
_aCeramides _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aChloramphenicol O-Acetyltransferase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCrotonates |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDithiothreitol _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aGenes, MDR _xdrug effects |
| 650 | 0 | 4 |
_aGenes, Reporter _xdrug effects |
| 650 | 0 | 4 | _aHost Cell Factor C1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrogen Peroxide _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHydroxybutyrates _xantagonists & inhibitors |
| 650 | 0 | 4 | _aI-kappa B Proteins |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aIsoxazoles _xantagonists & inhibitors |
| 650 | 0 | 4 | _aLeflunomide |
| 650 | 0 | 4 |
_aLipopolysaccharides _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLymphocyte Specific Protein Tyrosine Kinase p56(lck) _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMitogen-Activated Protein Kinase Kinases |
| 650 | 0 | 4 | _aNF-KappaB Inhibitor alpha |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aNF-kappa B p50 Subunit |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 | _aOctamer Transcription Factor-1 |
| 650 | 0 | 4 |
_aOkadaic Acid _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein Binding _xdrug effects |
| 650 | 0 | 4 | _aProtein Kinase Inhibitors |
| 650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xantagonists & inhibitors |
| 650 | 0 | 4 | _aToluidines |
| 650 | 0 | 4 |
_aTranscription Factor AP-1 _xmetabolism |
| 650 | 0 | 4 | _aTranscription Factor RelA |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aAggarwal, B B | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 162 _gno. 4 _gp. 2095-102 |
|
| 999 |
_c9935039 _d9935039 |
||